Safety and Retention Rate of the JAK and TNF Inhibitors in Rheumatoid Arthritis: a Real-life Experience

NCT05182203 · clinicaltrials.gov ↗

COMPLETED

Status

1732

Enrollment

OTHER_GOV

Sponsor class

Conditions

Rheumatoid Arthritis
Drug Use

Interventions

DRUG: biologic/targeted therapy

Sponsor

Tuen Mun Hospital